関連する実験動画
Updated: Jan 18, 2026

05:47
Animal Models of Depression - Chronic Despair Model CDM
Published on: September 23, 2021
8.0K
高齢期うつ病における神経調節と認知
Mina Mirjalili1, Daniel M Blumberger1,2,3, Andre R Brunoni4
1Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
まとめ
老年期うつ病は脳の可塑性を損ない、認知症のリスクを高めます。ECTやrTMSなどの非外科的神経調節は、高齢者の可塑性と認知機能を高める可能性を示しています。
科学分野:
- 神経科学
- 老年医学
- 精神医学
背景:
- 老年期うつ病(LLD)は、認知機能低下と認知症のリスク増加に関連しています。
- 様々な要因の影響を受ける大脳皮質のシナプス可塑性の障害は、LLDにおける重要な脆弱性です。
- うつ病における前頭前野の可塑性の障害は、認知症の病因に関与しています。
研究 の 目的:
- 老年期うつ病に関連する認知症のリスクにおける前頭前野の可塑性の障害の役割を調査すること。
- 大脳皮質の可塑性を誘発する非外科的神経調節技術をレビューすること。
- 老年期うつ病のための個別化されたメカニズムベースの介入の将来の方向性を探ること。
主な方法:
- LLD、認知機能低下、認知症のリスク、および大脳皮質の可塑性に関する既存の文献のレビュー。
- 可塑性を誘発する非外科的神経調節技術の分析:電気けいれん療法(ECT)、反復経頭蓋磁気刺激法(rTMS)、経頭蓋電気刺激法(tES)、および集束超音波療法(FUS)。
- 前臨床モデルと個別化された治療戦略の議論。
主要な成果:
- 前頭前野の可塑性の障害は、老年期うつ病と認知症を結びつける重要な要因です。
- 非外科的神経調節(ECT、rTMS、tES、FUS)は、大脳皮質の可塑性を高める可能性があります。
- これらの神経調節は、ネットワーク接続性と前頭前野機能を改善し、認知機能低下を軽減する可能性があります。
結論:
- 非外科的神経調節は、老年期うつ病における大脳皮質の可塑性と認知機能を改善するための有望な道を提供します。
- 前臨床研究に裏打ちされた個別化されたメカニズムベースの介入は、LLDの異質性に対処するために不可欠です。
- 個々の特性に基づいて治療を調整することで、LLD患者の転帰を改善し、認知症のリスクを低減できます。
関連する概念動画
Cognitive Development During Adulthood
783
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
783
Long-term Depression
3.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.1K
Long-term Depression
33.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.1K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
560
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
560
Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
Negative and Cognitive Symptoms of Schizophrenia
470
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
470

